カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ランレオチドの世界市場見通し2023年-2029年

◆英語タイトル：Lanreotide Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8538 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：74 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Lanreotide Market 調査レポートは次の情報を含め、グローバルにおけるのランレオチド市場規模と予測を収録しています。・世界のランレオチド市場：売上、2018年-2023年、2024年-2029年
・世界のランレオチド市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のランレオチド市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「60mg」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ランレオチドのグローバル主要企業は、IPSENなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ランレオチドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のランレオチド市場：タイプ別、2018年-2023年、2024年-2029年
世界のランレオチド市場：タイプ別市場シェア、2022年
・60mg、90mg、120mg

世界のランレオチド市場：用途別、2018年-2023年、2024年-2029年
世界のランレオチド市場：用途別市場シェア、2022年
・病院、薬局

世界のランレオチド市場：地域・国別、2018年-2023年、2024年-2029年
世界のランレオチド市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるランレオチドのグローバル売上、2018年-2023年
・主要企業におけるランレオチドのグローバル売上シェア、2022年
・主要企業におけるランレオチドのグローバル販売量、2018年-2023年
・主要企業におけるランレオチドのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
IPSEN

*************************************************************

・調査・分析レポートの概要
ランレオチド市場の定義
市場セグメント
世界のランレオチド市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のランレオチド市場規模
世界のランレオチド市場規模：2022年 VS 2029年
世界のランレオチド市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのランレオチドの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のランレオチド製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：60mg、90mg、120mg
ランレオチドのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
ランレオチドの用途別グローバル売上・予測

・地域別市場分析
地域別ランレオチド市場規模 2022年と2029年
地域別ランレオチド売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
IPSEN
...

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
This report aims to provide a comprehensive presentation of the global market for Lanreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lanreotide. This report contains market size and forecasts of Lanreotide in global, including the following market information:
Global Lanreotide Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Lanreotide Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Lanreotide companies in 2022 (%)
The global Lanreotide market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
60 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lanreotide include IPSEN. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lanreotide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lanreotide Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lanreotide Market Segment Percentages, by Type, 2022 (%)
60 mg
90 mg
120 mg
Global Lanreotide Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lanreotide Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Lanreotide Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lanreotide Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lanreotide revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Lanreotide revenues share in global market, 2022 (%)
Key companies Lanreotide sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Lanreotide sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IPSEN
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lanreotide, market overview.
Chapter 2: Global Lanreotide market size in revenue and volume.
Chapter 3: Detailed analysis of Lanreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lanreotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lanreotide capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Lanreotide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lanreotide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lanreotide Overall Market Size
2.1 Global Lanreotide Market Size: 2022 VS 2029
2.2 Global Lanreotide Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Lanreotide Sales: 2018-2029
3 Company Landscape
3.1 Top Lanreotide Players in Global Market
3.2 Top Global Lanreotide Companies Ranked by Revenue
3.3 Global Lanreotide Revenue by Companies
3.4 Global Lanreotide Sales by Companies
3.5 Global Lanreotide Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Lanreotide Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Lanreotide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lanreotide Players in Global Market
3.8.1 List of Global Tier 1 Lanreotide Companies
3.8.2 List of Global Tier 2 and Tier 3 Lanreotide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Lanreotide Market Size Markets, 2022 & 2029
4.1.2 60 mg
4.1.3 90 mg
4.1.4 120 mg
4.2 By Type – Global Lanreotide Revenue & Forecasts
4.2.1 By Type – Global Lanreotide Revenue, 2018-2023
4.2.2 By Type – Global Lanreotide Revenue, 2024-2029
4.2.3 By Type – Global Lanreotide Revenue Market Share, 2018-2029
4.3 By Type – Global Lanreotide Sales & Forecasts
4.3.1 By Type – Global Lanreotide Sales, 2018-2023
4.3.2 By Type – Global Lanreotide Sales, 2024-2029
4.3.3 By Type – Global Lanreotide Sales Market Share, 2018-2029
4.4 By Type – Global Lanreotide Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Lanreotide Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Lanreotide Revenue & Forecasts
5.2.1 By Application – Global Lanreotide Revenue, 2018-2023
5.2.2 By Application – Global Lanreotide Revenue, 2024-2029
5.2.3 By Application – Global Lanreotide Revenue Market Share, 2018-2029
5.3 By Application – Global Lanreotide Sales & Forecasts
5.3.1 By Application – Global Lanreotide Sales, 2018-2023
5.3.2 By Application – Global Lanreotide Sales, 2024-2029
5.3.3 By Application – Global Lanreotide Sales Market Share, 2018-2029
5.4 By Application – Global Lanreotide Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Lanreotide Market Size, 2022 & 2029
6.2 By Region – Global Lanreotide Revenue & Forecasts
6.2.1 By Region – Global Lanreotide Revenue, 2018-2023
6.2.2 By Region – Global Lanreotide Revenue, 2024-2029
6.2.3 By Region – Global Lanreotide Revenue Market Share, 2018-2029
6.3 By Region – Global Lanreotide Sales & Forecasts
6.3.1 By Region – Global Lanreotide Sales, 2018-2023
6.3.2 By Region – Global Lanreotide Sales, 2024-2029
6.3.3 By Region – Global Lanreotide Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Lanreotide Revenue, 2018-2029
6.4.2 By Country – North America Lanreotide Sales, 2018-2029
6.4.3 US Lanreotide Market Size, 2018-2029
6.4.4 Canada Lanreotide Market Size, 2018-2029
6.4.5 Mexico Lanreotide Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Lanreotide Revenue, 2018-2029
6.5.2 By Country – Europe Lanreotide Sales, 2018-2029
6.5.3 Germany Lanreotide Market Size, 2018-2029
6.5.4 France Lanreotide Market Size, 2018-2029
6.5.5 U.K. Lanreotide Market Size, 2018-2029
6.5.6 Italy Lanreotide Market Size, 2018-2029
6.5.7 Russia Lanreotide Market Size, 2018-2029
6.5.8 Nordic Countries Lanreotide Market Size, 2018-2029
6.5.9 Benelux Lanreotide Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Lanreotide Revenue, 2018-2029
6.6.2 By Region – Asia Lanreotide Sales, 2018-2029
6.6.3 China Lanreotide Market Size, 2018-2029
6.6.4 Japan Lanreotide Market Size, 2018-2029
6.6.5 South Korea Lanreotide Market Size, 2018-2029
6.6.6 Southeast Asia Lanreotide Market Size, 2018-2029
6.6.7 India Lanreotide Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Lanreotide Revenue, 2018-2029
6.7.2 By Country – South America Lanreotide Sales, 2018-2029
6.7.3 Brazil Lanreotide Market Size, 2018-2029
6.7.4 Argentina Lanreotide Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Lanreotide Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Lanreotide Sales, 2018-2029
6.8.3 Turkey Lanreotide Market Size, 2018-2029
6.8.4 Israel Lanreotide Market Size, 2018-2029
6.8.5 Saudi Arabia Lanreotide Market Size, 2018-2029
6.8.6 UAE Lanreotide Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 IPSEN
7.1.1 IPSEN Company Summary
7.1.2 IPSEN Business Overview
7.1.3 IPSEN Lanreotide Major Product Offerings
7.1.4 IPSEN Lanreotide Sales and Revenue in Global (2018-2023)
7.1.5 IPSEN Key News & Latest Developments
8 Global Lanreotide Production Capacity, Analysis
8.1 Global Lanreotide Production Capacity, 2018-2029
8.2 Lanreotide Production Capacity of Key Manufacturers in Global Market
8.3 Global Lanreotide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lanreotide Supply Chain Analysis
10.1 Lanreotide Industry Value Chain
10.2 Lanreotide Upstream Market
10.3 Lanreotide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lanreotide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Lanreotide in Global Market
Table 2. Top Lanreotide Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Lanreotide Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Lanreotide Revenue Share by Companies, 2018-2023
Table 5. Global Lanreotide Sales by Companies, (K Units), 2018-2023
Table 6. Global Lanreotide Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Lanreotide Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Lanreotide Product Type
Table 9. List of Global Tier 1 Lanreotide Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lanreotide Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Lanreotide Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Lanreotide Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Lanreotide Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Lanreotide Sales (K Units), 2018-2023
Table 15. By Type - Global Lanreotide Sales (K Units), 2024-2029
Table 16. By Application – Global Lanreotide Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Lanreotide Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Lanreotide Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Lanreotide Sales (K Units), 2018-2023
Table 20. By Application - Global Lanreotide Sales (K Units), 2024-2029
Table 21. By Region – Global Lanreotide Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Lanreotide Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Lanreotide Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Lanreotide Sales (K Units), 2018-2023
Table 25. By Region - Global Lanreotide Sales (K Units), 2024-2029
Table 26. By Country - North America Lanreotide Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Lanreotide Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Lanreotide Sales, (K Units), 2018-2023
Table 29. By Country - North America Lanreotide Sales, (K Units), 2024-2029
Table 30. By Country - Europe Lanreotide Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Lanreotide Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Lanreotide Sales, (K Units), 2018-2023
Table 33. By Country - Europe Lanreotide Sales, (K Units), 2024-2029
Table 34. By Region - Asia Lanreotide Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Lanreotide Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Lanreotide Sales, (K Units), 2018-2023
Table 37. By Region - Asia Lanreotide Sales, (K Units), 2024-2029
Table 38. By Country - South America Lanreotide Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Lanreotide Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Lanreotide Sales, (K Units), 2018-2023
Table 41. By Country - South America Lanreotide Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Lanreotide Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Lanreotide Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Lanreotide Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Lanreotide Sales, (K Units), 2024-2029
Table 46. IPSEN Company Summary
Table 47. IPSEN Lanreotide Product Offerings
Table 48. IPSEN Lanreotide Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. IPSEN Key News & Latest Developments
Table 50. Lanreotide Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Lanreotide Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Lanreotide Production by Region, 2018-2023 (K Units)
Table 53. Global Lanreotide Production by Region, 2024-2029 (K Units)
Table 54. Lanreotide Market Opportunities & Trends in Global Market
Table 55. Lanreotide Market Drivers in Global Market
Table 56. Lanreotide Market Restraints in Global Market
Table 57. Lanreotide Raw Materials
Table 58. Lanreotide Raw Materials Suppliers in Global Market
Table 59. Typical Lanreotide Downstream
Table 60. Lanreotide Downstream Clients in Global Market
Table 61. Lanreotide Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Lanreotide Segment by Type in 2022
Figure 2. Lanreotide Segment by Application in 2022
Figure 3. Global Lanreotide Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lanreotide Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Lanreotide Revenue, 2018-2029 (US$, Mn)
Figure 7. Lanreotide Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Lanreotide Revenue in 2022
Figure 9. By Type - Global Lanreotide Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Lanreotide Revenue Market Share, 2018-2029
Figure 11. By Type - Global Lanreotide Sales Market Share, 2018-2029
Figure 12. By Type - Global Lanreotide Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Lanreotide Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Lanreotide Revenue Market Share, 2018-2029
Figure 15. By Application - Global Lanreotide Sales Market Share, 2018-2029
Figure 16. By Application - Global Lanreotide Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Lanreotide Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Lanreotide Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Lanreotide Revenue Market Share, 2018-2029
Figure 20. By Region - Global Lanreotide Sales Market Share, 2018-2029
Figure 21. By Country - North America Lanreotide Revenue Market Share, 2018-2029
Figure 22. By Country - North America Lanreotide Sales Market Share, 2018-2029
Figure 23. US Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Lanreotide Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Lanreotide Sales Market Share, 2018-2029
Figure 28. Germany Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 29. France Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Lanreotide Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Lanreotide Sales Market Share, 2018-2029
Figure 37. China Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 41. India Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Lanreotide Revenue Market Share, 2018-2029
Figure 43. By Country - South America Lanreotide Sales Market Share, 2018-2029
Figure 44. Brazil Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Lanreotide Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Lanreotide Sales Market Share, 2018-2029
Figure 48. Turkey Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Lanreotide Revenue, (US$, Mn), 2018-2029
Figure 52. Global Lanreotide Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Lanreotide by Region, 2022 VS 2029
Figure 54. Lanreotide Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ランレオチドの世界市場見通し2023年-2029年(Lanreotide Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ランレオチドの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp